These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7974636)

  • 21. Ciprofloxacin-phenytoin interaction.
    Dillard ML; Fink RM; Parkerson R
    Ann Pharmacother; 1992 Feb; 26(2):263. PubMed ID: 1554944
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers.
    Vlase L; Popa A; Neag M; Muntean D; Leucuţa SE
    Eur J Drug Metab Pharmacokinet; 2011 Jan; 35(3-4):83-7. PubMed ID: 21302033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
    Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
    Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment: unexpectedly low phenytoin concentration in a patient receiving ciprofloxacin.
    McLeod R; Trinkle R
    Ann Pharmacother; 1998 Oct; 32(10):1110-1. PubMed ID: 9793610
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual effect of valproic acid on the pharmacokinetics of phenytoin.
    Lai ML; Huang JD
    Biopharm Drug Dispos; 1993 May; 14(4):365-70. PubMed ID: 8499586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.
    Kaucher KA; Acquisto NM; Rao GG; Kaufman DC; Huntress JD; Forrest A; Haas CE
    Pharmacotherapy; 2015 May; 35(5):482-8. PubMed ID: 26011141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.
    Issa MM; Nejem RM; El-Abadla NS; El-Naby MK; Roshdy AA; Kheiralla ZA
    Clin Drug Investig; 2007; 27(7):463-7. PubMed ID: 17563126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects.
    Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1990; 23(12):1315-21. PubMed ID: 2136565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy males.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Clin Pharmacol; 1997 Feb; 37(2):160-8. PubMed ID: 9055143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    Purkins L; Wood N; Ghahramani P; Love ER; Eve MD; Fielding A
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.
    Fischer TL; Pieper JA; Graff DW; Rodgers JE; Fischer JD; Parnell KJ; Goldstein JA; Greenwood R; Patterson JH
    Clin Pharmacol Ther; 2002 Sep; 72(3):238-46. PubMed ID: 12235444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin.
    Lai ML; Lin TS; Huang JD
    Eur J Clin Pharmacol; 1992; 43(2):201-3. PubMed ID: 1425879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Andrographis paniculata: Dissolution investigation and pharmacokinetic studies of four major active diterpenoids after multiple oral dose administration in healthy Thai volunteers.
    Pholphana N; Panomvana D; Rangkadilok N; Suriyo T; Puranajoti P; Ungtrakul T; Pongpun W; Thaeopattha S; Songvut P; Satayavivad J
    J Ethnopharmacol; 2016 Dec; 194():513-521. PubMed ID: 27702690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenytoin blood concentrations in hospitalized geriatric patients: oral versus nasogastric feeding tube administration.
    Lubart E; Berkovitch M; Leibovitz A; Orly D; Segal R
    Ther Drug Monit; 2010 Apr; 32(2):185-8. PubMed ID: 20216111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulation.
    Randinitis EJ; Buchanan RA; Kinkel AW
    Epilepsia; 1990; 31(4):458-64. PubMed ID: 2369880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ciprofloxacin in healthy Mexican volunteers.
    Escobar Y; Hoyo-Vadillo C
    Arzneimittelforschung; 2003; 53(9):664-7. PubMed ID: 14558441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in the bioavailability of phenytoin capsules in males and females.
    Meyer MC; Straughn AB; Mhatre RM; Shah VP; Chen ML; Williams RL; Lesko LJ
    Pharm Res; 2001 Mar; 18(3):394-7. PubMed ID: 11442282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin.
    Lolin YI; Ratnaraj N; Hjelm M; Patsalos PN
    Epilepsy Res; 1994 Oct; 19(2):99-110. PubMed ID: 7843173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.